Moderna Inc. is one of the frontrunner in the world's race to find a Covid vaccine, and the Trump administration has invested nearly half a billion dollars in its development.
US infectious disease expert Anthony Fauci said the trial, to be tested at 89 sites, is designed to show the vaccine is at least 60% effective in preventing Covid.
The primary goal of the final study, which will include 30,000 people, will be to show the vaccine prevents people from developing symptoms of Covid-19.
In a country where unemployment is at a historic high, the national anxiety isn’t about jobs — it’s about reach. Aspirations have shifted from employment to engagement, from careers to content.
COMMENTS